Related Experiment Video
Updated: Jun 1, 2026

A Flow Cytometry-based Assay for Measuring Mitochondrial Membrane Potential in Cardiac Myocytes After Hypoxia/Reoxygenation
Published on: July 13, 2018
ROS/SIRT1 signaling mediates mitochondrial dysfunction in hyperoxia-induced BEAS-2B cells injury
Kun Yang1, Ting He1, Rong Zhang1
1Department of Neonatology, Children's Medical Center, The Affiliated Hospital of Southwest Medical University, China.
Insights
Reactive oxygen species (ROS) and sirtuin 1 (SIRT1) play a role in lung injury in preterm infants. Targeting the ROS/SIRT1 pathway may offer new therapeutic strategies for bronchopulmonary dysplasia.
Area of Science:
- Cellular and Molecular Biology
- Neonatal Medicine
- Respiratory Medicine
Background:
- Bronchopulmonary dysplasia (BPD) is a prevalent chronic lung disease in preterm infants.
- Its complex pathogenesis necessitates research into cellular and molecular mechanisms.
- Understanding the role of reactive oxygen species (ROS) and sirtuin 1 (SIRT1) is crucial.
Purpose of the Study:
- To investigate the role of the ROS/SIRT1 axis in hyperoxia-induced injury in BEAS-2B cells.
- To explore potential therapeutic targets for BPD at the molecular level.
Main Methods:
- BEAS-2B cells were exposed to hyperoxia.
- Assays included cell counting kit-8, cell scratch, ROS assay, immunofluorescence, mitochondrial membrane potential assessment, transmission electron microscopy, and Western blot.
- The effects of a SIRT1 agonist and an ROS scavenger (N-Acetylcysteine) were evaluated.
Main Results:
- Hyperoxia increased ROS and decreased SIRT1 and mitochondria-associated proteins.
- SIRT1 activation reduced ROS, improved mitochondrial function, and reversed hyperoxia-induced damage.
- ROS scavenging also improved mitochondrial function and reversed molecular changes.
Conclusions:
- The ROS/SIRT1 axis is implicated in hyperoxia-induced mitochondrial injury in lung cells.
- SIRT1 represents a potential therapeutic target for bronchopulmonary dysplasia.
Background:
Bronchopulmonary dysplasia is a common chronic lung disease in preterm infants with a complex pathogenesis, and it is necessary to search for the potential pathogenesis and therapeutic strategies of bronchopulmonary dysplasia at the cellular molecular level. The present study investigated the role of reactive oxygen species (ROS)/sirtuin 1 (SIRT1) axis in hyperoxia-induced BEAS-2B cells injury.
Methods:
Cell counting kit-8, cell scratch, ROS assay, immunofluorescence, mitochondrial membrane potential, transmission electron microscopy assay and Western blot were performed to investigate the impairment of BEAS-2B by hyperoxia as well as the roles of SIRT1 and ROS in hyperoxia-induced BEAS-2B injury.
Results:
(1) Hyperoxia increased ROS in a time-dependent manner and decreased the levels of SIRT1 and mitochondria-associated proteins in BEAS-2B. (2) The SIRT1 agonist reduced ROS and improved mitochondrial membrane potential levels, attenuated mitochondrial fragmentation and mitochondrial morphological damage, and reversed the hyperoxia-induced decrease in mitochondria-associated proteins expression in BEAS-2B. (3) The ROS scavenger N-Acetylcysteine reduced ROS levels, improved mitochondrial membrane potential levels, attenuated mitochondrial morphological damage, and reversed the hyperoxia-induced decrease in SIRT1 and mitochondria-associated proteins levels in BEAS-2B.
Conclusion:
The ROS/SIRT1 axis is involved in hyperoxia-induced mitochondrial injury in BEAS-2B cells, and SIRT1 may be a potential therapeutic target for bronchopulmonary dysplasia.
Related Concept Videos
Peroxisomes
Cellular Injury I: Introduction
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes